The purpose of this study is to compare the effect of intravenous ropivacaine and lidocaine
on the receptive field of primary sensory afferents and their influence on the vascular bed.
*Trial with medicinal product
Drug: ropivacaine (Naropin)
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT00900913
Ages eligible for Study
18 Years to 65 Years
Genders eligible for Study
Accepts Healthy Volunteers
All locations for NCT00900913
Clinical Trial Center
View full eligibility
Tris trial is registered with FDA with number: NCT00900913. The sponsor of the trial is University of Zurich and it is looking for 34 volunteers for the current phase.
Official trial title: Effect of Systemic Ropivacaine on Hyperalgesia, Flare Reaction and Peripheral
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Thank you for applying!
We'll contact you soon with more information.
FindMeCure is constantly improving its search. Take part in it and help millions by filling our patients' survey!